Public recall detail

Hizentra (2020-01-16)

medium
Recall Safety notice
Quick summary

Quick summary: Hizentra (2020-01-16) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Hizentra (2020-01-16) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionHizentra, also known as immune globulin (human) 10 ml single used prefilled syringes DIN, NPN, DIN-HIM DIN 02463067 Dosage form Solution Strength Immunoglobulin (Human) 200 mg/mL Lot or serial number P100047093 Companies Recalling Firm CSL Behring Canada Inc. Suite 1460, 55 Metcalfe Street, Ottawa K1P 6L5 Ontario CANADA Marketing Authorization Holder CSL Behring Canada Inc. Suite 1460, 55 Metcalfe Street, Ottawa K1P 6L5 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...